INAB

IN8bio (INAB)

IN8bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INAB

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/06/14	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/06/14	05 : 01	GlobeNewswire Inc.	IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100	NASDAQ:INAB	IN8bio Inc
2024/06/03	21 : 53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/06/03	19 : 05	GlobeNewswire Inc.	IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/05/24	21 : 00	GlobeNewswire Inc.	IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024	NASDAQ:INAB	IN8bio Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/05/14	23 : 00	GlobeNewswire Inc.	IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress	NASDAQ:INAB	IN8bio Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024	NASDAQ:INAB	IN8bio Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INAB	IN8bio Inc
2024/05/10	05 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INAB	IN8bio Inc
2024/05/10	05 : 00	GlobeNewswire Inc.	IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:INAB	IN8bio Inc
2024/05/08	05 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:INAB	IN8bio Inc
2024/04/30	19 : 05	GlobeNewswire Inc.	IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma	NASDAQ:INAB	IN8bio Inc
2024/04/24	21 : 00	GlobeNewswire Inc.	IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/04/17	05 : 05	GlobeNewswire Inc.	IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference	NASDAQ:INAB	IN8bio Inc
2024/04/10	05 : 30	GlobeNewswire Inc.	IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024	NASDAQ:INAB	IN8bio Inc
2024/03/15	05 : 00	GlobeNewswire Inc.	IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	NASDAQ:INAB	IN8bio Inc
2024/03/06	06 : 30	GlobeNewswire Inc.	IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024	NASDAQ:INAB	IN8bio Inc
2024/02/26	22 : 00	Business Wire	IN8bio to Present at Upcoming Investor Conferences	NASDAQ:INAB	IN8bio Inc
2024/02/14	22 : 00	GlobeNewswire Inc.	IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc
2024/02/09	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INAB	IN8bio Inc